Checkpoint Blockade in COVID-19 Pandemic

NCT04335305 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Recruitment issues

Conditions

COVID-19
Pneumonia, Viral

Interventions

DRUG: Tocilizumab
BIOLOGICAL: Pembrolizumab (MK-3475)

Sponsor

MedSIR